chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. On 05-AUG-2014 the patient was vaccinated with ZOSTAVAX (lot #K000328, 0.65ml/once, subcutaneous). Pertinent medical history was not reported. Concomitant therapies included ABILIFY, REMERON (dose and frequency unknown), CYMBALTA, LAMICTAL and SEROQUEL. On 09-AUG-2014, the patient was seen at the pharmacy and stated that she has had short-term memory loss "since she got the shot". The outcome of short term memory loss is unknown. The causality was unknown. No further information was provided. Additional information has been requested.
cellulitis m/b & pain over  immunization site, Increased drainage, lymphangitis & lymphdenopathy at day 7, Primary reaction on revaccination (Prior vaccination as child, scar present), treated with 5 days of Levaquine
Welts on right side of stomach area, then 2 broke out on each arm. Last night got one on left side of face, below ear.  About size of dime, red, itchy.
Hives; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (Hives) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced URTICARIA (Hives). The patient was treated with PARACETAMOL (TYLENOL) for Hives, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency and HYDROCORTISONE ACETATE (HYDROCORTISONE [HYDROCORTISONE ACETATE]) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication not provided by the reporter.
07/07/22 presents to Triage for "scheduled repeat c/s". PMHx of "anemia, asthma"
Abnormal vaginal bleeding.  Started cycle about 5 days prior to vaccination and then bleeding continued for 3 weeks.
Moderate to Severe Urticaria on extremities, pruritic, now anxious as there has been no improvement since onset. Also worried about possible medium to long term sequlae like autoimmune nephropathy
In injected arm, redness spread from shoulder to almost elbow, swollen, throbbing, hot to touch, painful. Started afternoon after receiving and resolved after 3 to 4 days.
total time out of range is 2 days with a minimum of 9.2c and maximum of 28.3c, 30 minutes with a minimum of 12.3c and maximum of 15.6c, 1 hour with a minimum of negative 1.8c and maximum of 1.8c with no reported adverse event; Initial information received on 29-Apr-2022 regarding an unsolicited valid non-serious case received via other health professional.  This case involves a 64 years old and unknown gender patient who was administered vaccine with reported total time out of range is 2 days with a minimum of 9.2c and maximum of 28.3c, 30 minutes with a minimum of 12.3c and maximum of 15.6c, 1 hour with a minimum of negative 1.8c and maximum of 1.8c with no reported adverse event while receiving vaccine influenza quadrivalent recombinant vaccine (Flublok QIV).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect influenza quadrivalent recombinant vaccine with lot QFAA2125 and expiry date: 30-Jun-2022 (dose, route and administration site: unknown) for prophylactic vaccination.  On 17-Oct-2021, It was reported that temperature excursion of Flublok QIV vaccine occurred with total time out of range is 2 days with a minimum of 9.2c and maximum of 28.3c, on 19-Oct-2021,  temperature excursion occurred with 30 minutes with a minimum of 12.3c and maximum of 15.6c, 1 hour with a minimum of negative 1.8c and maximum of 1.8c with no reported adverse event (product temperature excursion issue).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event total time out of range is 2 days with a minimum of 9.2c and maximum of 28.3c, 30 minutes with a minimum of 12.3c and maximum of 15.6c, 1 hour with a minimum of negative 1.8c and maximum of 1.8c with no reported adverse event.
My second shot I got in the right side and had a headache, not a migraine this time, on the right side for a couple of days after the shot. (I am drinking lots of water.)
pt exp sl tremor noted hands clenched, body stiff, sl cyanosis to face, nonresponsive; unsure of what had happened; remained pale & clammy; sl nauseated;
2 days post vaccination, mild erythemia and slight swelling on the interior of left arm; not near injection site. Erythemia starts mid bicep and extends 4 inches below elbow. Pharmacist explained this is not an unusual reaction, but to watch it for worsening and go to urgent care/PCP if it doesn't resolve in a few days. Recommended applying ice x20 min on and off. Sent letter to PCP that day. Followed up with patient 1 week later and patient states "he's fine", the reaction has resolved on its own.
This spontaneous report was received from a pharmacy student refers to a patient of unknown gender and age. There was no information regarding the patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapy. Pharmacy student reported that on an unknown date, the patient was inadvertently vaccinated with an expired dose of VARIVAX by an unspecified physician. No adverse effect was reported. Additional information has been requested.
24 hours after injection patient developed fever, chills and had a near syncopal event and then developed herpes keratitis same day (has Hx of this)
pt recvd vax; t 103.6;dec to 101.4 w/ apap;extreme irritability; refusal to eat for 24 hrs; par did report this to ped; no tx deemed necessary
11:46 am.  Patient complained of dizziness and nausea.  11:48  BP 168/98;  p.78.  R 14.  O2 Sats 97% .  Provided Water, cereal snack.  VS 12:05 BP  150/90 - P. 70  R16.  SAT 98%. Resolution of s/s at 12:15.  Discharged home.
Swollen, red, hard and feverish knot at injection site.  Severe headache and slept  for over 24 hours.  Was unable to leave bed for 24 hours except for necessities and experienced dizziness and disorientation when trying to get up.  Fever over 100 degrees and no appetite and no food taken.  Still no appetite on 02/27/21.
Difficulty walking. Her legs were not working; Runny nose; Pfizer Covid Booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Nov2021 14:30 (Lot number: FH8U30) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "injury to her tail bone", start date: 2005 (unspecified if ongoing); "Schizophrenia" (unspecified if ongoing). Concomitant medication(s) included: ARISTADA taken for schizophrenia (ongoing). Vaccination history included: Bnt162b2 (Dose 2, Lot number: EW0161, had no problems with the two vaccines), administration date: 29Apr2021, when the patient was 58 years old, for Covid-19 immunization, reaction(s): "had no problems with the two vaccines"; Bnt162b2 (Dose 1, Lot number: EW0153, had no problems with the two vaccines), administration date: 06Apr2021, when the patient was 58 years old, for Covid-19 immunization, reaction(s): "had no problems with the two vaccines". The following information was reported: IMMUNISATION (non-serious) with onset 24Nov2021 14:30, outcome "unknown", described as "Pfizer Covid Booster"; RHINORRHOEA (non-serious) with onset 25Nov2021, outcome "recovered" (26Nov2021), described as "Runny nose"; GAIT DISTURBANCE (non-serious) with onset 27Nov2021, outcome "not recovered", described as "Difficulty walking. Her legs were not working". The event "difficulty walking. her legs were not working" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rhinorrhoea.  Additional information: Concomitant Products Aristada the last shot she received was 15Oct2021. She saw the doctor on Tuesday 30Nov2021 because her legs were not working. The runny nose was from Thursday 25Nov2021, Friday 26Nov2021. She took over the counter medication, Coriciden HP, it has runny nose on the label.  Investigations: Went to the doctor's office Tuesday 30Nov2021. When went to doctor's office they were unsure if event was from covid vaccine or from previous injuries. She had x-rays that day, but had no results to provide.  Additional Vaccines Administered on Same Date of the Pfizer Suspect: None. Adverse Event (AE) Details: Provide the time of onset of AE(s): Adverse Event: Runny nose, Time of Onset: (24-hour clock): In the evening about 4-5'clock. Adverse Event:  Difficulty Walking, Time of Onset: (24-hour clock): When got out of bed in the morning. Did any AE(s) require a visit to: Emergency Room? No, Physician Office? Yes, because of difficulty walking, legs not working. Prior Vaccinations (within 4 weeks): None. AE(s) following prior vaccinations: None. Patient's Medical History (including any illness at time of vaccination)? None. At end of call, caller commented and requested if we find out if any issues or if anyone had side effects related to this lot number could we let her doctor know.  No follow-up attempts are possible. No further information is expected.
In the afternoon on 01/30/2023, I began to feel tired. More tired than I expected to be at that time of day. I was at work and I left work at the usual time around 4:30PM and I felt like I was coming down with a cold. By that evening, I was more tired and a little congested. I slept for a good 9 hours which is 2 hours longer than usual for me. I got up and called work and told them I wouldn't be in that day. On 01/31/2023, I was very congested, head congestion. No chest congestion. I thought I had a cold but I kept falling asleep. I took 3 naps that day 1 1/2 hours each which is unusual for me. Later that evening, I took a home test and it came back positive immediately. I alerted my employer that I wouldn't be in. I stayed home the rest of that week as well as the weekend, and I did return to work on Monday 02/06/2023. It was like a bad cold with a lot of fatigue. Slight headache on and off. I reported the positive test to my doctor on Wednesday morning and left a phone message. I didn't hear back from them until Thursday and they had sent in a prescription for PAXLOVID. My wife picked it up and I took the medication as directed. I started feeling better about Friday afternoon. Between Thursday and after the 3rd dose of PAXLOVID, I started to feel better. I took that until 02/06/2023 which was my last dose. I still felt like I had a head cold for part of that second week but I was no longer positive for COVID-19. I took another home test on Thursday 02/02 and I was positive. I took another test 02/05/2023 and I was negative. During my COVID-19 infection, I did also lose my sense of taste and smell on 02/03/2023, but that felt like more of a side effect of PAXLOVID. I didn't lose those senses until I took that medication. It took about 24 hours after my final dose on Monday to get those back. They slowly returned over the next week or so.
Vaccines were administer at the 15 month visit (5/19/21). In the past month, mom has reached out to clinic to share observation that Liam had regression in skills (language, eye contact) that she associates in timing with his 15 month vaccine.  (The day of, immediately following). Patient had previous speech delay diagnosis at 12 months. Mom notes increasing concerns for his language and also for sensory sensitivities. He is followed by EI and being referred to developmental neuro pediatrics and further evaluations.
This is a spontaneous report from a Pfizer sponsored program. A contactable Health Care Professional reported similar events for three patients. This 1st of three reports. This Health Care Professional reported for a male patient (son). A male patient of an unspecified age, race and ethnicity received  TRUMENBA on an unknown date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, after the vaccination, the patient became ill and experienced pretty bad fatigue, fever and feeling crummy. Clinical outcome of the adverse events was unknown at time of this report. No follow-up attempts possible. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2017503287 Same Reporter, Different Patient.
Immediately following administration of the vaccine, patient complained of radiating pain from her left shoulder across her back and down her arm.  Patient was asked to stay in the store for evaluation. After another five minutes, the patient complained of numbness on the left side of her face. The patient then decided to leave the pharmacy. The following day the pharmacist followed up with the patient and she reported that her symptoms had resolved completely.
Diffuse redness, swelling, itching and pain at injection site (left deltoid). Eventual residual was hyperpigmetation, nodular mass (2" diameter).
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered from an expired vial/doses administered >12 hours post puncture) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered from an expired vial/doses administered >12 hours post puncture). On 22-Jan-2022, EXPIRED PRODUCT ADMINISTERED (doses administered from an expired vial/doses administered >12 hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment medications were provided. On 13 Jan 2022, the vial was initially stored in the fridge. On 21 Jan 2022 9:21 PM, vial was first punctured. No temperature excursions were reported. This case was linked to MOD-2022-459581, MOD-2022-459566 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2022: Follow up was received and suspect drug details and details of the storage was updated.
This spontaneous report as received from a pharmacist refers to multiple unspecified patients who on 04-FEB-2013 were vaccinated with doses of GARDASIL (from lot # H017698, expiry on 02-JUL-2015), M-M-R II (from either lot# 0425AE, expiry on 27-FEB-2014 or from lot# 0367AE, expiry on 15-FEB-2014) that were exposed to an unsupported temperatured excursion. No patient specific information was provided. It was unknown if any patients received both GARDASIL and M-M-R II. No adverse effects were reported. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Initially went to get out of bed to use the restroom but was so lightheaded, I stayed on my bed for at least 10 more minutes sitting up.  Finally it passed.  When I woke up in the morning, for the next 3 days, I had excruciating pain in my shoulder blade area and also in my inner left hip area.
an expired Hepatitis B vaccine was administered; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were not reported.        On 10-NOV-2020, the patient was vaccinated with the second dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (lot # R021370 with expiration date 07-NOV-2020; dose and route were not provided) for prophylaxis (expired vaccine used).
Shingles, 3 month after I got the shot/ suspected vaccination failure; bad case of Shingles, came down with it with a bang; 3 years of awful rash on the whole right side of my face eye; 3 years of awful pain on the whole right side of my face eye. able to keep right eye open now; 3 years of awful pain on the whole right side of my face eye. able to keep right eye open now; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rash, eye pain and facial pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the rash, eye pain and facial pain were recovering/resolving.   It was unknown if the reporter considered the vaccination failure, shingles, rash, eye pain and facial pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient. The age at vaccination was not reported. The patient developed a bad case of Shingles 3 month after receiving the Shingles shot. The patient was just getting to a low pain level with it after 3 years of awful rash and pain on the whole right side of her face and eye. The patient was able to keep right eye open at the time of reporting and stated that it has improved a lot on the reporting month. The patient came down with shingles with a bang when she lost her husband of 68 years with a heart attack. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule and laboratory confirmation for shingles were unknown.
This spontaneous report as received from a healthcare worker refers to multiple patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown dates, improperly stored doses of M-M-R II (lot # L001336, exp. 13-JAN-2017 (route of administration, dose were not reported) were administered to unspecified patients. There was no adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient came back after few days with c/o swelling and redness around injection site. Her half of her arm was red. Patient brought a Rx for Prednisone after seeing her MD. RPH called patient in few days to check to see how she was doing.
Hospitalized 9/28/21 with COVID 19  Pneumonia.  He was recently admitted at outside hospital, for epigastric pain, thought to be secondary to constipation.  Found to be hypoxic, and COVID 19 positive. He completed 5 days of Remdesivir and was discharged home on 9/22/21 to complete his Dexamethasone. He was discharged on 2L NC supplemental oxygen.  He states his shortness of breath never improved, and called EMS, and was found to have oxygen saturation of 70% on RA.
Presented with AMS, fatigue; Labs:  D-dimer 0.59; CRP: 5.08; Ferritin: 178; CXR: mild atelectasis or infiltrates; Tx: Decadron, Remdesivir, Vit C, Vit D3, Lovenox, singulair, zinc,  Initially FiO2 @ 2 LPM, max dose was 4LPM; back to room air prior to d/c
Friday, 9/7 within 3 hrs of injection, arm where 2 vaccines administered swelled. Flu & PNEUMOVAX vaccine given in left arm. Pt called to MD next morn Sat. MD said to ice it & prescribed cephalexin. Swelling subsided Mon am. 3 days after injection.
3-28-07 Rec'd Varicella immunization.  3-29-07 Redness/Swelling of left upper arm - induration 2" x 3". 3-30-07 States swelling down from yesterday.
the bottom of the eyelid being swollen; This is a spontaneous report from a contactable consumer. This consumer (parent- mother) reported for a patient (son). A 24-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0185, Expiration date: UNKNOWN), via an unspecified route of administration, administered in Arm Left on 18May2021, around 19:00 (at the age of 24-year-old) as dose 1, single for covid-19 immunisation. The patient Patient's Medical History(including any illness at time of vaccination was none. The patient was healthy. The concomitant medications were not reported. No additional vaccines administered on same date of the Pfizer suspect. Prior vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was provided as no. The Reporter reported that her son received the first injection of the Pfizer covid-19 vaccine on 18May2021, and later that day started experiencing the bottom of the eyelid being swollen. Maybe three or three and a half hours after receiving the first dose Pfizer COVID-19 Vaccine, the bottom eyelid swelled up: The Reporter states it is her son's bottom right eyelid, it was a little swollen, a little red in the corner and now it looks like her son got punched in the eye. The Reporter states her son's eyelid is not bruised, but it is swollen. Reports it has worsened since Tuesday night, 18MAY2021. The Reporter stated her son's eyelid was now more swollen and almost like where you get dark circles under your eyes. It looked similar to what it would look like if someone punched him in the eye. The Reporter was not sure if this was a reaction to the first dose Pfizer COVID19 Vaccine. The Reporter showed photos to an allergist, the allergist does not think it was from the Pfizer COVID-19 Vaccine but is not sure. The allergist told the Reporter to apply cold compresses on her son's eyelid and go from there. She was asking whether her son should receive the second Pfizer COVID-19 injection or not since he had this reaction after the first. Reporter seriousness for the event was unspecified. Adverse event did not required a visit to Emergency Room or Physician Office. Relevant tests performed was reported as none. The outcome of event was not recovered.  Information on Lot/Batch number was available. Additional information has been requested.  Follow-up attempts have been completed and no further information is expected.
Chills which turned to a low grade fever, tingling in extremities, and the fever of 100 continued through the 14th.  Then, legs and feet went numb.  On 1/18, upper back pain and tingling in hands began.  Still no feeling in legs or feet.  Some difficulty walking.
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated IM with a dose of MMR II. Subsequently in the patient's arm that vaccine was given, the arm locked up. The patient received the dose of "MMR II" as a split dose with one half being administered in each arm. The arm released after 2 day to 4 weeks. As of 12-APR-2011, the patient had recovered. It was unspecified if the patient sought medical attention. Arm locking up was considered to be disabling by the reporter. This is one of several reports received from the same source. This case was that resolved the fastest among these series of cases. Additional information has been requested.
Soreness around injection site. Extreme pain in neck, shoulders, arms, hips and legs. Saw Doctor 01/07/2013 for blood tests. Saw Doctor again 01/17/2013 for more blood work. Saw Doctor 1/23/2013 for sedimentation rate blood work. 01/25/2013 received diagnosis of Polymyalgia Rheumatica, began 15mg Prednisone 1x/day and 800mg Ibuprofen 3x/day. Symptoms persist, extreme pain and sleeplessness despite medication.